Rankings
▼
Calendar
CRON Q2 2022 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$983M
Q2 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$28M
+78.0% YoY
Gross Profit
$6M
20.0% margin
Operating Income
-$33M
-117.1% margin
Net Income
-$26M
-93.6% margin
EPS (Diluted)
$-0.05
QoQ Revenue Growth
-2.0%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$19M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$61M
Stockholders' Equity
$1.7B
Cash & Equivalents
$1.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$28M
$16M
+78.0%
Gross Profit
$6M
-$16M
+135.2%
Operating Income
-$33M
-$60M
+45.9%
Net Income
-$26M
-$179M
+85.5%
Revenue Segments
Cannabis Flower
$16M
68%
Cannabis Extracts
$7M
31%
Product and Service, Other
$281,000
1%
Geographic Segments
CANADA
$14M
62%
ISRAEL
$7M
31%
UNITED STATES
$1M
6%
← FY 2022
All Quarters
Q3 2022 →